1104 Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) With Relapsed and Newly Diagnosed Active Lupus Nephritis (LN)

• Brad H Rovin,
• Hans-Joachim Anders,
• Ming-hui Zhao,
• Ana Malvar,
• David A Roth,
• Keiju Hiromura,
• Jennifer Gilbride,
• Yulia Green,
• Anuradha Madan,
• Angela Jones- Leone,
• Tania Gonzalez-Rivera

Affiliations

Brad H Rovin

4 Division of Nephrology, Department of Medicine, The Ohio State University, Columbus, Ohio, USA

Hans-Joachim Anders

2 Medizinische Klinik and Poliklinik IV, University of Munich, Munich, Germany

Ming-hui Zhao

3Peking University First Hospital, Beijing, China

Ana Malvar

10 Organización Médica de Investigación, Buenos Aires, Argentina

David A Roth

Immunoinflammation, GSK, Collegeville, PA, USA

Keiju Hiromura

5Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine, Maebashi, Japan

Jennifer Gilbride

7GSK, Stevenage, Hertfordshire, UK

Yulia Green

GSK, Uxbridge, London, UK

Anuradha Madan

GSK, Collegeville, Pennsylvania, USA

Angela Jones- Leone

6GlaxoSmithKline, Collegeville, PA, USA

Tania Gonzalez-Rivera

6GlaxoSmithKline, Collegeville, PA, USA